Affinity Technologies, Inc. ( ($BIAF) ) has issued an update. On October 16, 2025, bioAffinity Technologies, Inc. announced it received a ...
Investing.com -- bioAffinity Technologies Inc (NASDAQ:BIAF) stock surged 14% on Thursday after the biotechnology company announced it received a notification of allowance from the United States Patent ...
The Galleri MCED test is a blood-based targeted methylation test that detects cancer signals from cell-free DNA in blood ...
The US Patent and Trademark Office will issue BIAF a new patent on its flow cytometry+AI platform that detects lung cancer as ...
Development and Validation of an Ipsilateral Breast Tumor Recurrence Risk Estimation Tool Incorporating Real-World Data and Evidence From Meta-Analyses: A Retrospective Multicenter Cohort Study Data ...
An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results. Results ...
The global Early-Stage Lung Cancer Diagnostics Therapy Market is entering a transformative decade. With its valuation ...
A study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with ...